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disorders. The oral cavity, inhabited by 500 different species of microorganism forming biofilm, is a very important potential site of initiation and propagation of such low-grade inflammation. While numerous studies have focused on the role of periodontitis or periapical changes as sites of origin of low-grade inflammation, 2 recent studies have suggested that DS might also represent such chronic low-grade inflammation.
The systemic characteristics of T cells or monocytes in DS have not been described. DS is a fungal infection, most commonly with Candida species. These species are part of the commensal flora of the oral cavity; however, the combination of denture presence with factors such as low salivary pH, high sugar consumption, 3 or low saliva flow contributes to excessive fungal growth. Mucosal immune responses to fungal pathogens include neutrophils as major effectors of the innate response, driven by cytokines released from epithelial cells after contact with pathogens. 4, 5 However, epithelial cells also produce β-defensin 2 and CCL20, orchestrating dendritic cell recruitment, 6 which present fungal antigens to the T cell. It was long thought that Th1 were the leading type of response for fungal infection, but after discovering the existence of IL-17 producing Th17 cells, this type of immune reaction appears to be vital, 7 with suppressive T regulatory (Treg) cells playing a role in counter-balancing the Th17 response. 6 Mice lacking IL-17 signaling (IL-23 −/− or IL-17A receptor −/− ) are more susceptible to oral candidiasis than wild-type mice. 8 Similarly, in humans, genetic variations of IL-17-related genes are associated with increased susceptibility [9] [10] [11] [12] to chronic mucocutaneous candidiasis. It remains unclear how these local immune responses reflect changes in systemic immunity and subpopulations of proinflammatory T cells and monocytes in the peripheral blood of DS patients. Limited studies suggest that oral candidal infection may impact peripheral blood mononuclear cells, and cytokine production in vitro in response to Candida antigens 13, 14 is altered, although it is not clear which type of cell, monocytes or lymphocytes, primarily respond.
Therefore, the aim of our study was to determine whether the local inflammation caused by the presence of denture-related stomatitis coincides with the systemic inflammatory response, depicted as activation of peripheral blood immune cells.
Materials and methods

Patients and clinical evaluation
Consecutive patients using dental prostheses for at least 6 months were recruited to the study and assigned to two groups: DS patients (n = 20) and control non-DS (n = 24) subjects, who presented with healthy oral mucosa.
1 Detailed methodology, clinical data acquisition, and exclusion criteria along with major systemic clinical features were described previously. 1 In brief, patients' oral mucosa was examined to detect the presence of clinical symptoms of DS such as erythema and swelling. Additionally, patients' subjective complaints, such as discomfort and pain in the palatal area, were registered. The swabs from the inflamed area were taken for routine microbiological laboratory diagnostic tests for Candida species presence to confirm clinical diagnosis. Swabs were taken from the hard palate (between the second and third palatal fold). Samples were collected after an overnight fast and after at least 6 hours of continuous denture use, without the use of adhesives or rinsing the mouth with disinfectants. Samples were collected by gently rubbing a sterile cotton swab moist with saline over the palatal tissue and then subsequently inoculating a primary isolation in dextrose agar transport medium. The collected sample was transported to the laboratory immediately after the patients' visit. Candida identification was made according to the color of the colony on CHROMagar Candida medium (Graso Biotech, Starogard Gdański, Poland) after 36 to 48 hours of incubation at 36°C. Patients were recruited to the DRS group when clinical symptoms were confirmed by positive microbiological culture of Candida species from the palatal tissue. In patients with some teeth present, the periodontal examination was conducted to exclude patients with periodontitis (one or more periodontal pocket depth ࣙ4 mm). Exclusion criteria also included acute inflammatory disorders and chronic inflammation other than DS, neoplastic disease and relapses and chemotherapy courses less than 5 years before the enrollment, antibiotic usage in the past 4 weeks, or anti-inflammatory drug regimen (steroids and non-steroidal, excluding aspirin in doses less than 80 mg) in the past 2 months before enrollment. Patients with a history of myocardial infarction, acute coronary incident, or vascular inflammation in 5 weeks or less before the enrollment, chronic haematological disorders, and immunodeficiency or major medication changes less than 5 weeks before or during study were also excluded.
The study was independently reviewed and approved by the local ethics committee of Jagiellonian University, Cracow, Poland. Written informed consent was obtained from all patients, and the study was conducted in accordance with the Declaration of Helsinki. This study has been registered in ClinicalTrials.gov (identification no. NCT02166450). Information about systemic risk factors of DS such as diabetes (fasting glucose level ࣙ7 mmol/l or HbA1c >6.5% or current treatment with insulin or oral hypoglycaemic agents) and smoking (current or within last 6 months) were based on patient medical records and detailed patient history. The definition of clinical risk factors was based on European Guidelines on cardiovascular disease prevention in clinical practice from 2012.
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Extracellular cytometric analysis
Blood samples were collected in ethylenediaminetetraacetic acid-containing tubes (Becton Dickinson [BD], Franklin Lakes, NJ). Peripheral blood mononuclear cells (PBMC) were isolated using Lymphocyte Separation Medium LSM 1077 (PAA Laboratories GmbH, Pasching, Austria). After isolation, cells were washed twice with phosphate-buffered saline (PBS) with heatinactivated 1% fetal bovine serum (Gibco, Life Technologies, Carlsbad, CA) and then incubated for 20 minutes at 4°C with fluorescently labeled monoclonal antibodies (all antibodies were purchased from BD Pharmingen, San Diego, CA). After washing, cells were re-suspended in PBS with 1% fetal bovine serum, and studied on a FACSCanto II or FACSVerse cytometer (BD Bioscences, San Jose, CA). Results were analyzed using FlowJo vX software (FLOWJO LCC Data Analysis Software, Ashland, OR). Lymphocytes were identified in PBMC on forward-scattered light channel (FSC)/ side-scattered light channel (SSC) scatter plots, and T cell presence was confirmed by CD3 staining. Percentages of naive (CD45RA+) and memory (CD45RO+) and CD4+ and CD8+ T cells were assessed, as well as the presence of surface activation markers in these subpopulations. Monocytes were also identified on FSC/SSC scatter plots with confirmation of CD14/human leukocyte antigens (HLA)-DR staining. Three main populations were assessed among monocytes: CD14highCD16-, CD14dimCD16+, and CD14highCD16+. The following monoclonal antibodies were used: anti-CD3-PerCP (clone SK7),
For technical reasons, it was impossible to perform monocyte analysis in one patient in the DS group.
Intracellular cytometric analysis
Cytokine production by T cells was assessed after 4-hour incubation of PBMC in Roswell Park Memorial Institute medium 1640 (Gibco, Life Technologies) with 10% fetal bovine serum (Gibco, Life Technologies), gentamycin, and L-glutamine (Sigma, Saint Louis, MO) with stimulation with Leukocyte Activation Cocktail with BD GolgiPlug (BD Pharmingen). After 20 minutes of on-ice staining for cell surface markers (CD3, CD4, and CD8; procedure, suppliers and clones as presented above), cells were washed with PBS with heat-inactivated 1% fetal bovine serum. Cells were permeabilized (20 minutes, on ice) (BD Cytofix/Cytoperm, Fixation and Permeabilization Solution, BD Pharmingen) and, after washing with BD PermWash Buffer (BD Pharmingen), stained for intracellular cytokines for 20 minutes, on ice. Then the cells were washed again with BD PermWash Buffer, resuspended in PBS with 1% fetal bovine serum, and studied by flow cytometry, as described for the extracellular staining procedure. The following monoclonal antibodies were used: anti-IL-17-PE (clone N49-653), anti-IL-4-PE (clone 8D4-8), anti-TNFα-FITC (clone MAb11), and anti-IFNγ -FITC (clone B27). Non-specific staining with isotype-matched control monoclonal antibodies was used (PE Mouse IgG1κ Isotype Control, clone MOPC-21 and FITC Mouse IgG1κ Isotype Control, clone MOPC-21). All antibodies were from BD Pharmingen, San Diego, CA.
Statistical analysis
Assessment of normality of distribution for all continuous variables was conducted by the Shapiro-Wilk test. Variables whose distributions were not consistent with a normal distribution were presented as median and 25th (Q1) and 75th (Q3) percentiles and tested by the Mann-Whitney U test. Variables with normal distribution were presented as means with standard deviations (SD) and tested with Student's t-test. Dichotomous variables were tested by the chi 2 test for the expected frequencies ࣙ 5. If the expected frequencies < 5, Yates' correction was applied, and Fisher's exact test was executed for confirmation. Values of p < 0.05 were considered statistically significant. All analyses were performed with Statsoft Statistica software (StatSoft, Inc., Tulsa, OK).
Results
Patient characteristics
DS and non-DS groups were comparable in relation to age (mean ± SD: 64 ± 7 and 66 ± 10, respectively), gender (2M/18F and 6M/18F, respectively), and major clinical characteristics (Table 1 ). Compared to the general population, the proportion of females was higher in both groups using dental prostheses. Proportions of smokers (30% and 12.5%) and diabetic patients (30% and 8.3%) were higher in the DS group, as these factors are key risk factors for DS, but the difference did not reach statistical significance. A clinical description of DS and control group patients is presented in Table 1 . Detailed characteristics describing cardiovascular status of study group patients were published in a previous article. 1 Most of the screened participants were edentulous (n = 36).
Lymphocyte characterization in peripheral blood of DS patients
Percentages of total lymphocytes and T cells in peripheral blood mononuclear cell (PBMC) of DS and control patients showed no significant differences (Fig 1A upper panel) . Similarly no differences were observed in CD4+ and CD8+ T cell subsets (Fig 1A lower panel) CCR7-) , and memory (CD45RA-CCR7+) T cells from both CD4+ and CD8+ populations, also did not show any differences between the groups (Fig 2A) . 
Lymphocyte activation in peripheral blood of DS patients
Interestingly, we found that the median percentages of cells expressing late activation marker CD25 from CD4+ and CD8+ subsets were significantly lower in the DS group (p = 0.0006 and 0.0076, respectively), but there were no differences between the groups in percentages of CD4+ and CD8+ expressing early activation marker CD69 (Fig 3A) . Percentages of CD4+ and CD8+ CD28null subsets were also similar in both groups (Fig 3A) . (Fig 3A) . These differences were not statistically significant.
CD25high T regulatory cells in DS
As CD25+ cells represent both late activation marker-bearing cells and T regulatory suppressive cells, we next investigated the characteristics of CD25+ cells taking into account that CD25high T cells represent typically the naturally occurring regulatory T cells in humans 16 ( Fig 3C) . Consequently, the percentage of CD25high cells was lower in DS patients than in controls in the CD4+ T cell subset ( Fig 3B) ; however, the difference in CD25high cells was not significant in CD8+ T cells.
T cell cytokine production in DS
We next performed intracellular staining to investigate major proinflammatory cytokine production in peripheral blood T cells in DS. There was no significant difference in IL-17, IFN-γ , and TNF-α production between the healthy and DS groups. Additionally, we did not see a difference in IL-4 cytokine production (Fig 4) .
Monocyte characteristics in the peripheral blood of DS patients
As peripheral blood monocyte subpopulation changes might also reflect systemic chronic inflammation, we next analyzed monocyte subsets based on CD14+ and CD16+ expression. We found no statistically significant differences in percentages of monocytes present in the peripheral blood of both groups, as well as in percentages of three subsets of these cells: CD14highCD16-, CD14highCD16+, and CD14dimCD16+ (Fig 5) .
Discussion
Denture-related stomatitis is an inflammatory process of the oral mucosa with increasing importance in the aging of populations, as it is one of the most common diseases among elderly denture wearers. 17, 18 It affects around 15 to 70% of individuals older than 65 and is most common in complete prosthesis users. [17] [18] [19] The prevalence range described in the literature is wide, most probably because of different population samples investigated in different studies, but generally it appears to be more common in women 17 and in diabetic and smoking patients. 20 The systemic nature of immune activation in fungal infection of the palatal tissue described as DS is still unclear. According to our hypothesis, the presence of DS in the oral cavity might lead to the chronic, low-grade systemic inflammation caused by persistent fungal infection; however, we did not observe any relationship between the presence of this condition and the percentage of lymphocytes and T cells present in the peripheral blood in this study. The same observation was also true for CD4+ and CD8+ T cell subsets. Lack of differences in CD4+ T cell subsets was the most surprising, as this lymphocyte subset is thought to be of great importance in Candida immunity. 21 However, in our study group the fungal infection was connected with an exogenous (denture), not endogenous (immunosuppression caused by a viral pathogen) factor; thus the immune response may have different characteristics. Naive (CD45RA+), memory (CD45RO+), and CD28null T cell subsets were studied, because DS is frequently asymptomatic and can persist untreated for long periods of time, and persistent infection provoking continuous immune activation may accelerate the senescence of CD8+ T cells marked by loss of CD28 marker. 22 CCR5 gene expression was shown to be enhanced in peripheral blood monocytes stimulated with C. albicans in vitro, 23 and PBMC were shown to secrete RANTES in response to C. albicans presence. 24 Therefore we studied the expression of chemokine RANTES receptor CCR5 on T cells. Groups did not differ regarding these cell subpopulations, probably reflecting the predominantly local nature of inflammatory response in the oral mucosa in DS, which was clinically evident. We also compared the amount of monocytes and their subpopulations between groups, as these cells and their differentiated form-macrophages-are elements of the first line of immunologic defense against invading pathogens. Similarly, local inflammation on the oral mucosa in DS was not associated with changes of monocyte subsets; however, monocytes are known to play an important role in inflammatory diseases such as rheumatoid arthritis (RA) or atherosclerosis. 25 ,26 It appears that CD16+ subsets are especially vital, and their role in inflammatory conditions was described previously in end-stage renal disease and in active RA. 25, 27 Changes in monocyte subpopulations are visible even at very early stage of disease, 28 with an increased amount of intermediate (CD14highCD16+) and a decreased amount of non-classical (CD14dimCD16+) monocytes.
In summary, lack of differences in peripheral blood immune cell subtypes may point to the lack of systemic response to oral C. albicans infection. While this is contrary to our hypothesis, we believe that this is a very important consideration for interpretation of some systemic features of DS.
While no differences were identified in our study in relation to naïve, effector, or other T cell or pro-inflammatory monocyte subsets, we observed a lower occurrence of T cells positive for late activation markers, namely CD25, in the peripheral blood of DS patients. While CD25 is classically induced by activation, it is also characteristic for naturally occurring T regulatory cells, 29 which are characterized by a particularly high expression of CD25 (CD4+CD25high). While we have not studied transcription factor characteristic for Tregs-FoxP3, our preliminary experiments showed that CD4+CD25high T cells express FoxP3 in peripheral blood in humans. Treg cells have a suppressive effect in relation to the immune system, which, under physiological conditions, is very important for the proper regulation of immune response. 29 In that regard, lower levels in DS patients could seem counterintuitive or indicate their exit to inflammed tissues and lower ability toward resolution of chronic inflammation, which could promote DS. Importance of T regulatory cells has, however, been emphasized in immune response to candidosis, during which their predominant function seems to be related to promoting pro-inflammatory Th17-type immune response, while suppressing other arms of immune response, which is vital for clearance of fungal infections. 30 Patients with a low number of functional Treg cells, known as IPEX (Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked), caused by mutations in the FoxP3 gene are susceptible to infections, including Candida. 31 Finally, decreased CD4+CD25high T cells could provide a link between chronic oral inflammation in DS and risk factors such as diabetes. Indeed, diabetic individuals were overrepresented in the DS study group, and the presence of this condition is associated with lower numbers of CD25+ T cells. 32 These results may suggest that lower CD4+CD25+ T cells in DS could link these two conditions mechanistically, although subsequent studies characterizing these mechanisms are warranted. Thus, unexpectedly, our results may point our attention toward a possible mechanism of chronic inflammation in DS patients rather than showing systemic consequences of this process.
Our study has some limitations-all of the experiments were performed in a relatively small number of patients and, as such, should be considered preliminary, although to date no other study has systematically addressed the issue of peripheral T cell and monocyte activation in relation to DS. It should also be kept in mind that the presence of confounders, such as diabetes mellitus or smoking, although not statistically significant, can affect the results. While the studied group was insufficient to control for these factors statistically, we should bear in mind that these are genuine and strong risk factors of the disease, so lack of difference between groups would render this comparison clinically less meaningful. The caution is also warranted when making wide conclusions on the general population, as the predominance of women in both study groups was obvious, although again linked to DS epidemiology. Finally, while cytometric methods used in the present study are considered sensitive and accurate, their sensitivity may not be sufficient to detect extremely subtle differences in markers and mediators. 33 However, such differences would be unlikely to have clinical relevance.
Conclusion
Although immune mechanisms involved in the local immune defense against oral fungal infection are very complex and include various cell types-not only immune cells, 4, 21, 34 but also epithelial cells of the infected tissues 35 -the main observation of our work is the lack of the evidence of systemic cellular response to oral C. albicans infection. At the same time, differences regarding CD4+CD25high+ T cell subsets may point to the potential role of Treg cells in susceptibility of diabetic patients to denture-related stomatitis. Knowledge of the detailed mechanism responsible for increasing DS risk in diabetics may allow for an effective prevention of oral fungal infections in this population, thus improving comfort of denture use and patient quality of life. Prevention of DS might also be of particular importance, in light of our previous work, where a higher prevalence of endothelial dysfunction in DS patients was observed. 1 Endothelial dysfunction as a symptom preceding the development of atherosclerosis 36 may have serious consequences for the health and life of the patients. Therefore, reducing the risk of its occurrence constitutes an important clinical goal. A growing body of evidence suggests that Th17 immune response, plays an important role in immune responses to mucosal and cutaneous candidosis. 37 The recently discovered role of these proinflammatory mechanisms in hypertension 38, 39 makes these immune cells a particularly interesting target for research looking into the mechanisms linking oral and cardiovascular disease.
